Wong, H. et al. 2009. Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors. Acta Oncologica. 48, 8 (Jan. 2009), 1213–1215. DOI:https://doi.org/10.3109/02841860902980453.